Skip to content
Screener

Twist Bioscience Corporation TWST Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Danaher logo
DanaherDHR
$1.2B+9.1%
Azenta logo
AzentaAZTA
$61.42M
Illumina logo
IlluminaILMN
$371M-9.5%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
5.9%0.0pp
GeneDx Holdings logo
GeneDx HoldingsWGS
$34.65M+39.3%
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands except years and percentage)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Operating lease costs$3,347$3,738$6,903$7,477
Variable lease costs$2,058$1,888$4,130$3,808
Sublease income$681$1,419
Weighted-average remaining lease term (in years) - operating leases14.114.7
Weighted-average discount rate - operating leases6.9%6.3%

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's operating lease ROU assets?
Twist Bioscience Corporation (TWST) reported operating lease ROU assets of 6.9% in Q1 2026.
How has Twist Bioscience Corporation's operating lease ROU assets changed year-over-year?
Twist Bioscience Corporation's operating lease ROU assets increased by 9.5% year-over-year, from 6.3% to 6.9%.
What is the long-term trend for Twist Bioscience Corporation's operating lease ROU assets?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's operating lease ROU assets has grown at a -5.4% compound annual growth rate (CAGR), from 6,158,000,000% to 4,937,700,000%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Twist Bioscience Corporation's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude